Dr. Milena Pavlova, MD

Dr. Pavlova practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Pavlova's NPI, 1043276306, was assigned on April 25, 2006. Dr. Pavlova graduated from Medical University of Sofia FOM in 1992. Dr. Pavlova holds Massachusetts license 213330.

Dr. Pavlova's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Pavlova's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Pavlova is also affiliated with Brigham and Women's Faulkner Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Pavlova to 1 more hospital outpatient department, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pavlova practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Pavlova's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Pavlova is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dr. Pavlova is licensed in Massachusetts.

Dmand AI lists cerebrovascular disease, hypersomnia, migraine and chronic headache, restless legs syndrome, seizures and sleep apnea among the conditions Dr. Pavlova treats.

CMS data shows 376 Medicare services from Dr. Pavlova across 11 procedure codes in 2024, for 283 Medicare patients. Medicare paid $37,151 for them.

CMS counts 283 Medicare patients who saw Dr. Pavlova in 2024. The largest group is 65 to 74, with 113 patients. 74% of them have high cholesterol, and 72% have high blood pressure. 23% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pavlova's median patient age at 63, with 51% women.

In 2024, Dr. Pavlova wrote 276 Medicare Part D claims for 58 patients. 87% of them were for generic drugs. CMS names the drug for 125 of them, across 7 drugs with 11 or more claims each, at $4,764 in total drug cost. In 2023, CMS named 151 claims across 10 drugs.

Dr. Pavlova accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pavlova as offering telehealth.

Dmand AI links 105 papers to Dr. Pavlova, published from 2004 to 2024. 2021 was the busiest year, with 13. The most frequent topics are Electroencephalography, Sleep and Epilepsy. Dr. Pavlova has published most often in BMC Health Serv Res. Dr. Pavlova's most frequent co-authors are Sanjeev V. Kothare, MD, Rani Sarkis, MD and Lawrence Jay Epstein, MD.

Dmand AI links Dr. Pavlova to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Ischemic Stroke and Sleep Apnea, Obstructive.

CMS Open Payments shows 34 general payments to Dr. Pavlova from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 52% of the total. Jazz Pharmaceuticals Inc. paid the most, $17,184.

Dr. Pavlova graduated from Medical University of Sofia FOM in 1992.

Dr. Pavlova is in network with 17 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.